Bayer Snaps Up Teva Animal Health Unit In $145M Deal

Law360, New York (September 14, 2012, 12:24 PM EDT) -- The animal health arm of German pharmaceutical giant Bayer AG has agreed to swallow up the substantially smaller U.S. pet and livestock health business of Teva Pharmaceutical Industries Ltd. in a deal that could be worth as much as $145 million, the companies said Friday.

Bayer will pay $60 million in cash up front for the Missouri-based Teva unit and tack on up to $85 million in additional future payments tied to the achievement of manufacturing and sales goals on a set timetable. The companies did...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.